Oefner Lab - Collaborators
- Wolfram Klapper, Universitätsklinikum, Schleswig-Holstein; Sektion für Hämatopathologie
- Gerhard Liebisch, University Hospital, Regensburg, Germany
im Rahmen des ETZ Freistaat Bayern - Tschechische Republik, 2014 - 2020 (INTERREG V) - Petr Simek, Biologické centrum AV CR, Budweis Czech Republic
im Rahmen des ETZ Freistaat Bayern - Tschechische Republik, 2014 - 2020 (INTERREG V) - Mark Allen, Advion BioSciences Ltd, Norfolk, UK
- Günther Bonn, Institute of Analytical Chemistry and Radiochemistry,University of Innsbruck, Austria
- Georgia Chenevix-Trench, The Queensland Institute of Medical Research, Brisbane, Australia
- Ronald W. Davis, Stanford Genome Technology Center, Palo Alto, CA, USA
- Marc Feldman, Department of Biological Sciences, Stanford University, CA, USA
- Lukas Huber, Division of Cell Biology, Innsbruck Medical University, Austria
- Toomas Kivisild, Estonian Biocentre,Tartu, Estonia
- Reinhard Kofler, Division of Molecular Pathophysiology, Innsbruck Medical University, Austria
- Holger Prokisch & Thomas Meitinger, GSF National Research Center, Neuherberg, Germany
- John Ross & Marcel Vlad, Department of Chemistry, Stanford University, CA, USA
- Nicola Zamboni & Uwe Sauer, Institute of Biotechnology, ETH Zürich,Switzerland
- Marina Kreutz & Reinhard Andreesen, Dept. of Hematology and Medical Oncology, University of Regensburg, Germany
- Thomas Langmann & Gerd Schmitz, Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany
- David Camp & Richard Smith, Pacific Northwest National Laboratory, Batelle, WA, USA
- Zlatko Trajanoski, Institute of Genomics and Bioinformatics, Technical University Graz, Austria
- Dennis P. Wall, Department of Systems Biology, Harvard Medical School, Boston, MA, USA
- Masha Yuneva, University of California San Francisco, CA, USA